Last updated 31 January 2007

Important Notice: This database is designed to be used by researchers. Patients and caregivers are directed to consult Clinicaltrials.Gov for more information on how to enroll in specific trials. (See also Schizophrenia.com page on Medications in Development) Neither Schizophrenia Research Forum nor the author(s) of these data will respond to specific questions from the public about the information in this table. Schizophrenia Research Forum does not provide medical advice or promote any product or service. The contents are for informational purposes only and are not intended to substitute for professional medical advice, diagnosis, or treatment. Always seek advice from a qualified physician or health care professional about any medical concern, and do not disregard professional medical advice because of anything you may read on this website.

Created and updated by Hugo Geerts, In Silico Biosciences

The overarching goal of this database is to serve as an unbiased, centralized, publicly available and regularly updated collection of ongoing clinical studies in schizophrenia. The primary goal is also to provide information on trials where reducing clinical symptomatology (i.e., positive, negative, and cognitive deficits) in schizophrenia is a primary goal, rather than trials where specific comedications are tested to address drug-specific side-effects. To ensure a high degree of objectivity regarding the posted information, only publicly available information, such as found on the U.S. Government Clinical Trials website or the Stanley Medical Research Foundation website, in addition to specific company websites, is used for inclusion into the database.

While we have made every possible effort to correctly represent the data of all studies fulfilling the above criteria we cannot exclude the possibility that some studies are cited incorrectly or were erroneously excluded. Therefore, we are not able to make any warranty, either expressed or implied, with respect to the functioning and accuracy of this database. No responsibility is assumed by the authors and curators.

If you detect an error in the data or want to submit general concerns, comments and suggestions about the database, please contact us. We encourage clinicians responsible for novel investigator initiated clinical trials to submit your data.

Drugs in Clinical Trials for Schizophrenia—Posted 31 January 2007
By Hugo Geerts